Literature DB >> 27794082

Impact of Noninvasive Ventilation on Lung Volumes and Maximum Respiratory Pressures in Duchenne Muscular Dystrophy.

Dante Brasil Santos1,2, Isabelle Vaugier3, Ghilas Boussaïd1, David Orlikowski3,4, Hélène Prigent1,5, Frédéric Lofaso6,5.   

Abstract

BACKGROUND: Duchenne muscular dystrophy (DMD) is a sex-linked genetic disorder in which progressive impairment of skeletal muscle function eventually leads to severe respiratory failure requiring continuous noninvasive ventilation (NIV) at home. A current focus of debate is whether NIV may slow the decline in respiratory function or, on the contrary, worsen respiratory function when started early. Our objective here was to describe the effects of NIV on vital capacity (VC) and maximum respiratory pressures in DMD.
METHODS: We analyzed retrospective data from 71 subjects with DMD, including VC, maximum static respiratory pressures, and sniff nasal inspiratory pressure before and after NIV initiation. The declines in these variables from the highest value to the most recent value were computed.
RESULTS: Although respiratory function continued to deteriorate over time, NIV introduction was followed by significant slowing in the annual rates of decline in VC (from 4.28 to 1.36 percent predicted), maximum inspiratory pressure (from 2.77 to 1.48 cm H2O), and maximum expiratory pressure (from 2.00 to 1.00 cm H2O). NIV had no effect on sniff nasal inspiratory pressure.
CONCLUSIONS: Introducing NIV in subjects with DMD was followed by slowing of the declines in VC and in maximum static inspiratory and expiratory pressures.
Copyright © 2016 by Daedalus Enterprises.

Entities:  

Keywords:  Duchenne muscular dystrophy; follow-up; neuromuscular disease; noninvasive ventilation

Mesh:

Year:  2016        PMID: 27794082     DOI: 10.4187/respcare.04703

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  5 in total

1.  Liberation and mortality outcomes in pediatric long-term ventilation: A qualitative systematic review.

Authors:  Candice M Foy; Monica L Koncicki; Jeffrey D Edwards
Journal:  Pediatr Pulmonol       Date:  2020-08-12

2.  Characterization of sleep-disordered breathing in children with Duchenne muscular dystrophy by the American Academy of Sleep Medicine criteria vs disease-specific criteria: what are the differences?

Authors:  Manju S Hurvitz; Kanokkarn Sunkonkit; Colin Massicotte; Rhondda Li; Rakesh Bhattacharjee; Reshma Amin
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

3.  Effect on lung function of mounthpiece ventilation in Steinert disease. A case report.

Authors:  Anna Annunziata; Giuseppe Fiorentino; Antonio Esquinas
Journal:  Acta Myol       Date:  2017-03

4.  Early NIV is associated with accelerated lung function decline in Duchenne muscular dystrophy treated with glucocorticosteroids.

Authors:  Megan E Angliss; Kiara D Sclip; Leanne Gauld
Journal:  BMJ Open Respir Res       Date:  2020-02

5.  Transition from Childhood to Adulthood in Patients with Duchenne Muscular Dystrophy.

Authors:  Eliza Wasilewska; Sylwia Małgorzewicz; Agnieszka Sobierajska-Rek; Joanna Jabłońska-Brudło; Lucyna Górska; Karolina Śledzińska; Joanna Bautembach-Minkowska; Jolanta Wierzba
Journal:  Medicina (Kaunas)       Date:  2020-08-24       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.